scholarly article | Q13442814 |
P356 | DOI | 10.1002/14651858.CD013251 |
P932 | PMC publication ID | 6353059 |
P2093 | author name string | Eu Chang Hwang | |
Philipp Dahm | |||
Jae Hung Jung | |||
Tae Wook Kang | |||
Myung Ha Kim | |||
Michael Borofsky | |||
P2860 | cites work | The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration | Q21092360 |
What is "quality of evidence" and why is it important to clinicians? | Q24647929 | ||
Minimally invasive devices for treating lower urinary tract symptoms in benign prostate hyperplasia: technology update | Q26796381 | ||
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials | Q27860509 | ||
Measuring inconsistency in meta-analyses | Q27860655 | ||
Does Greenlight HPS™ Laser Photoselective Vaporization Prostatectomy Affect Sexual Function? | Q85235340 | ||
Patients not P values | Q87137164 | ||
Prostatic urethral lift for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia | Q92287898 | ||
Quantifying heterogeneity in a meta-analysis | Q27860672 | ||
GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables | Q29547885 | ||
Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials | Q29620299 | ||
Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey | Q30004207 | ||
The Epidemiology of Benign Prostatic Hyperplasia Associated with Lower Urinary Tract Symptoms: Prevalence and Incident Rates | Q30248685 | ||
Relationships among participant international prostate symptom score, benign prostatic hyperplasia impact index changes and global ratings of change in a trial of phytotherapy in men with lower urinary tract symptoms | Q30414602 | ||
Sexual dysfunction in men after treatment for lower urinary tract symptoms: evidence from randomised controlled trial | Q30703497 | ||
Morbidity and mortality after benign prostatic hyperplasia surgery: data from the American College of Surgeons national surgical quality improvement program | Q30755126 | ||
Proportion of tadalafil-treated patients with clinically meaningful improvement in lower urinary tract symptoms associated with benign prostatic hyperplasia – integrated data from 1,499 study participants | Q30848036 | ||
Rezūm System Water Vapor Treatment for Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia: Validation of Convective Thermal Energy Transfer and Characterization With Magnetic Resonance Imaging and 3-Dimensional Renderings | Q30953856 | ||
Transurethral holmium laser enucleation of the prostate versus transurethral electrocautery resection of the prostate: a randomized prospective trial in 200 patients | Q33205987 | ||
Is transurethral resection of the prostate still justified? | Q33610894 | ||
Perspective on the Rezūm® System: a minimally invasive treatment strategy for benign prostatic hyperplasia using convective radiofrequency water vapor thermal therapy. | Q33631315 | ||
Meta-analysis of Functional Outcomes and Complications Following Transurethral Procedures for Lower Urinary Tract Symptoms Resulting from Benign Prostatic Enlargement | Q33687864 | ||
The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association | Q33846043 | ||
Benign prostatic hyperplasia: from bench to clinic | Q34216723 | ||
Baseline characteristics predict risk of progression and response to combined medical therapy for benign prostatic hyperplasia (BPH). | Q34506218 | ||
Measurement of health status. Ascertaining the minimal clinically important difference | Q34515517 | ||
A Systematic Review and Meta-analysis of Functional Outcomes and Complications Following Transurethral Procedures for Lower Urinary Tract Symptoms Resulting from Benign Prostatic Obstruction: An Update | Q35196664 | ||
ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions | Q37335426 | ||
GRADE guidelines: 9. Rating up the quality of evidence | Q37908614 | ||
Patient-reported outcomes in meta-analyses--Part 1: assessing risk of bias and combining outcomes | Q38118394 | ||
Non-randomized studies as a source of complementary, sequential or replacement evidence for randomized controlled trials in systematic reviews on the effects of interventions | Q38520315 | ||
Relationship Between Depression and Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia | Q38843896 | ||
Procedural techniques and multicenter postmarket experience using minimally invasive convective radiofrequency thermal therapy with Rezūm system for treatment of lower urinary tract symptoms due to benign prostatic hyperplasia | Q39150470 | ||
Two-year results after convective radiofrequency water vapor thermal therapy of symptomatic benign prostatic hyperplasia | Q39163003 | ||
Development and validation of four-item version of Male Sexual Health Questionnaire to assess ejaculatory dysfunction | Q39796278 | ||
National Trends of Simple Prostatectomy for Benign Prostatic Hyperplasia With an Analysis of Risk Factors for Adverse Perioperative Outcomes. | Q41480287 | ||
Update on AUA guideline on the management of benign prostatic hyperplasia | Q44411654 | ||
Morbidity, mortality and early outcome of transurethral resection of the prostate: a prospective multicenter evaluation of 10,654 patients | Q46793850 | ||
Baseline factors as predictors of clinical progression of benign prostatic hyperplasia in men treated with placebo | Q46974519 | ||
Risk factors for progression or improvement of lower urinary tract symptoms in a prospective cohort of men. | Q48171211 | ||
The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. | Q50951063 | ||
Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7). | Q53295449 | ||
GRADE guidelines 6. Rating the quality of evidence—imprecision | Q57269328 | ||
Surgical Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline | Q67223710 | ||
Benign prostatic hyperplasia specific health status measures in clinical research: how much change in the American Urological Association symptom index and the benign prostatic hyperplasia impact index is perceptible to patients? | Q71752227 | ||
The natural history of patients with benign prostatic hyperplasia as diagnosed by North American urologists | Q71926905 | ||
Pathology of benign prostatic hyperplasia | Q82570613 | ||
P433 | issue | 1 | |
P921 | main subject | prostatic hypertrophy | Q506659 |
P577 | publication date | 2019-01-27 | |
P1433 | published in | Cochrane Database of Systematic Reviews | Q15750361 |
P1476 | title | Convective radiofrequency water vapor thermal therapy for lower urinary tract symptoms in men with benign prostatic hyperplasia | |
P478 | volume | 2019 |